Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment
- 2 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (11) , 3610-3618
Abstract
To phenotype SLE based on symptom burden (disease damage, system involvement and patient reported outcomes), with a specific focus on objective and subjective cognitive function. SLE patients ages 18–65 years underwent objective cognitive assessment using the ACR Neuropsychological Battery (ACR-NB) and data were collected on demographic and clinical variables, disease burden/activity, health-related quality of life (HRQoL), depression, anxiety, fatigue and perceived cognitive deficits. Similarity network fusion (SNF) was used to identify patient subtypes. Differences between the subtypes were evaluated using Kruskal–Wallis and χ2 tests. Of the 238 patients, 90% were female, with a mean age of 41 years (s.d. 12) and a disease duration of 14 years (s.d. 10) at the study visit. The SNF analysis defined two subtypes (A and B) with distinct patterns in objective and subjective cognitive function, disease burden/damage, HRQoL, anxiety and depression. Subtype A performed worst on all significantly different tests of objective cognitive function (P < 0.03) compared with subtype B. Subtype A also had greater levels of subjective cognitive function (P < 0.001), disease burden/damage (P < 0.04), HRQoL (P < 0.001) and psychiatric measures (P < 0.001) compared with subtype B. This study demonstrates the complexity of cognitive impairment (CI) in SLE and that individual, multifactorial phenotypes exist. Those with greater disease burden, from SLE-specific factors or other factors associated with chronic conditions, report poorer cognitive functioning and perform worse on objective cognitive measures. By exploring different ways of phenotyping SLE we may better define CI in SLE. Ultimately this will aid our understanding of personalized CI trajectories and identification of appropriate treatments.Keywords
Funding Information
- Arthritis Society of Canada
- Canadian Institutes of Health Research
- Physician’s Services Incorporated
- Province of Ontario Early Research
- Lupus Research Alliance
- Department of Medicine, University of Toronto
This publication has 46 references indexed in Scilit:
- Screening for Cognitive Impairment in Systemic Lupus ErythematosusThe Journal of Rheumatology, 2012
- Cognitive impairment in fibromyalgia syndrome: The impact of cardiovascular regulation, pain, emotional disorders and medicationEuropean journal of pain, 2011
- Cardiovascular Disease Risk Factors and Cognition in the ElderlyCurrent Cardiovascular Risk Reports, 2011
- The effect of pain on cognitive function: A review of clinical and preclinical researchProgress in Neurobiology, 2011
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsAnnals of the Rheumatic Diseases, 2010
- A re-examination of pain–cognition interactions: Implications for neuroimagingPain, 2007
- Depression, fatigue, and pain in systemic lupus erythematosus (SLE): Relationship to the American College of Rheumatology SLE neuropsychological batteryArthritis Care & Research, 2006
- Construct and Concurrent Validity of the Hopkins Verbal Learning Test – RevisedThe Clinical Neuropsychologist, 1999
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient GroupsMedical Care, 1994